11 news items
Coya Therapeutics Expands Sponsored Research Collaboration with Houston Methodist Research Institute Along with Funding from the Johnson Center for Cellular Therapeutics to Advance Regulatory T Cell Exosome Platform into the Clinic
COYA
20 Jun 24
for our product candidates, and our ability to serve those markets; our commercialization, marketing and manufacturing capabilities and strategy; future
Coya Therapeutics Announces Publication of ALS Study in Peer-Reviewed Journal Frontiers in Neurology
COYA
11 Jun 24
commercialization, marketing and manufacturing capabilities and strategy; future agreements with third parties in connection with the commercialization
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
COYA
3 Jun 24
and strategy; future agreements with third parties in connection with the commercialization of our product candidates; our expectations regarding our
Coya Therapeutics Announces Inclusion in the MSCI USA Micro Cap Index
COYA
28 May 24
and manufacturing capabilities and strategy; future agreements with third parties in connection with the commercialization of our product candidates; our
EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases
BIIB
COYA
27 May 24
?’
Berman: “New cancer immunotherapies paved the road to developing multi-targeted treatment strategies to fight disease
nmfzpi3cdo
COYA
22 May 24
commercialization, marketing and manufacturing capabilities and strategy; future agreements with third parties in connection with the commercialization of our
aknpj397wguoecpjxfndycdo9a
COYA
20 May 24
candidates, and our ability to serve those markets; our commercialization, marketing and manufacturing capabilities and strategy; future agreements
vg9xpocu884i3biy871szssopsr dkzv5xd7o1i99l2my5y3
COYA
9 May 24
neurodegenerative diseases (ALS, PD, FTD, and AD) – Coya to leverage data from the Ph. 2 LD IL-2 study in AD to inform on strategy and next steps
0sjmlqf97h56oc95uujtid4tohtbx99zgissql79o3pe269zemx
COYA
26 Apr 24
; our commercialization, marketing and manufacturing capabilities and strategy; future agreements with third parties in connection
lm9tt93tct3a 5xb5h7q290f
COYA
18 Apr 24
ability to serve those markets; our commercialization, marketing and manufacturing capabilities and strategy; future agreements with third parties
m6x85
COYA
8 Apr 24
and manufacturing capabilities and strategy; future agreements with third parties in connection with the commercialization of our product candidates; our
- Prev
- 1
- Next